PortfoliosLab logoPortfoliosLab logo

Janus Henderson Global Life Sciences Fund Class T (JAGLX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with JAGLX. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to JAGLX

JAGLX charges 0.92% annually. There are 23 mutual funds in the Health & Biotech Equities category with lower expense ratios, going as low as 0.10%.


Best Risk-Adjusted Alternatives to JAGLX

JAGLX has a PortfoliosLab risk / return rank of 85. There are 13 mutual funds in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.


Top Performing JAGLX Alternatives (YTD)

JAGLX is at 7.67% YTD. There are 22 mutual funds in the Health & Biotech Equities category with higher YTD returns, going as high as 22.25%.


Lowest Volatility Alternatives to JAGLX

JAGLX has 15.87% 1-year volatility. There are 12 mutual funds in the Health & Biotech Equities category with lower 1-year volatility, going as low as 14.15%.


Lowest Drawdown Alternatives to JAGLX

JAGLX has a 1-year max drawdown of -9.71%. There are 16 mutual funds in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -7.62%.


Other Mutual Funds from Janus Henderson

The 10 most viewed Janus Henderson mutual funds shown here include JNGTX, JNRFX, JAGTX and span 7 categories.


Often Compared With JAGLX

Investors most often compare JAGLX with VHT, JNGLX, IHF. These 20 comparison targets span 5 categories, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnAUMInception
Vanguard Health Care ETFHealth & Biotech Equities
57
4.62%
19.00BJan 2004JAGLX vs VHT
Janus Henderson Global Life Sciences FundHealth & Biotech Equities
85
7.73%
Dec 1998JAGLX vs JNGLX
iShares U.S. Healthcare Providers ETFHealth & Biotech Equities
42
18.38%
1.20BMay 2006JAGLX vs IHF
iShares U.S. Pharmaceuticals ETFHealth & Biotech Equities
94
17.43%
1.34BMay 2006JAGLX vs IHE
Janus Henderson Global Life Sciences Fund Class AHealth & Biotech Equities
85
7.62%
Dec 1998JAGLX vs JFNAX
VanEck Vectors Biotech ETFHealth & Biotech Equities
61
7.78%
400.02MDec 2011JAGLX vs BBH
Fidelity Global ex U.S. Index FundForeign Large Cap Equities
60
13.29%
Aug 2011JAGLX vs FSGGX
iShares U.S. Healthcare ETFHealth & Biotech Equities
47
3.21%
3.21BJun 2000JAGLX vs IYH
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
88
12.62%
9.35BFeb 2001JAGLX vs IBB
iShares U.S. Medical Devices ETFHealth & Biotech Equities
3
-19.59%
3.14BMay 2006JAGLX vs IHI
Invesco DWA Basic Materials Momentum ETFMomentum, Materials
31
9.67%
75.77MOct 2006JAGLX vs PYZ
T. Rowe Price Health Sciences FundHealth & Biotech Equities
55
6.60%
Dec 1995JAGLX vs PRHSX
SPDR S&P Pharmaceuticals ETFHealth & Biotech Equities
93
21.59%
479.61MJun 2006JAGLX vs XPH
Janus Henderson VIT Global Technology and Innovati...Technology Equities
49
26.50%
Jan 2000JAGLX vs JGLTX
Eventide Healthcare & Life Sciences FundHealth & Biotech Equities
89
9.55%
Dec 2012JAGLX vs ETIHX
SPDR S&P Biotech ETFHealth & Biotech Equities
95
28.25%
11.10BFeb 2006JAGLX vs XBI
Vanguard Information Technology ETFTechnology Equities
57
23.92%
170.10BMar 2004JAGLX vs VGT
Alger Health Sciences FundHealth & Biotech Equities
92
15.61%
Apr 2002JAGLX vs AHSAX
Putnam Global Health Care FundHealth & Biotech Equities
36
2.92%
May 1982JAGLX vs PHSTX
Perkins Discovery FundHealth & Biotech Equities
27
4.76%
Apr 1998JAGLX vs PDFDX

Compare JAGLX with Any Fund or Stock

Compare JAGLX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair JAGLX with funds that move differently

Janus Henderson Global Life Sciences Fund Class T alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to JAGLX.

Explore JAGLX Diversifiers